Site Search
Use small fonts Use medium fonts Use large fonts Email link to page


To Engage or Not to Engage: Guidance on Motions to Strike a Within Application

Published: 03/08/2017

By A. Chandimal Nicholas

The Federal Court has reaffirmed and clarified how a pharmaceutical brand company should respond to a generic company’s motion to strike an application for abuse of process under s. 6(5)(b) of the Patented Medicines (Notice of Compliance) Regulations.

Read more about the Federal Court reaffirmation.